Hi ,
Iam sure I read many posts here stating that the FDA was to fast track the OXYPATCH and sales would be just a few years,
Goldenchook posted a $150 to $200 mill pharma deal.
It turns out the CEO waters down the hype with a realistic time frame.
Which oddly enough was the time I thought if it progresses.
Another capital raise?
Regards.
esra oxypatch 4 years.
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 34259955 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 40753304 | 27 |
View Market Depth
| Last trade - 16.12pm 07/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable